Neoplasm Clinical Trials Database - Free Access to 405 Studies
Access comprehensive clinical trial information for Neoplasm through Pure Global AI's free database. This collection includes 405 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 74 trials are actively recruiting participants.
Research for Neoplasm is being conducted in China, United States of America, Japan and 7+ other countries. Leading sponsors include GlaxoSmithKline and Novartis. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Dose Escalation and Expansion Study of SAR444200 in Adult Participants With Advanced Solid Tumors
Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors
Untitled Trial
Untitled Trial
Untitled Trial
Untitled Trial
Untitled Trial
Untitled Trial
Untitled Trial
Untitled Trial
Untitled Trial
Untitled Trial
Untitled Trial
Untitled Trial
Modern Hybrid Imaging in Patients With OSCC
Untitled Trial
Untitled Trial
Untitled Trial
Untitled Trial
Untitled Trial
Pure Global AI provides free access to 405 clinical trials studying Neoplasm, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include GlaxoSmithKline, Novartis, Wyeth, among others.